Related Experiment Video
Updated: Jan 20, 2026

Nitropeptide Profiling and Identification Illustrated by Angiotensin II
Published on: June 16, 2019
Angiotensin II and aldosterone in retinal vasculopathy and inflammation
Jennifer L Wilkinson-Berka1, Varaporn Suphapimol1, Jack R Jerome1
1Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, Victoria, Australia; Department of Diabetes, The Central Clinical School, Monash University, Melbourne, Victoria, Australia.
Abstract:
Angiotensin II and aldosterone are the main effectors of the renin-angiotensin aldosterone system (RAAS) and have a central role in hypertension as well as cardiovascular and renal disease. The localization of RAAS components within the retina has led to studies investigating the roles of angiotensin II, aldosterone and the counter regulatory arm of the pathway in vision-threatening retinopathies. This review will provide a brief overview of RAAS components as well as the vascular pathology that develops in the retinal diseases, retinopathy of prematurity, diabetic retinopathy and neovascular age-related macular degeneration. The review will discuss pre-clinical and clinical evidence that modulation of the RAAS alters the development of vasculopathy and inflammation in the aforementioned retinopathies, as well as the emerging role of aldosterone and the mineralocorticoid receptor in central serous chorioretinopathy.
Related Concept Videos
Inflammation
Hormonal Regulation
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Induced Pluripotent Stem Cells

